Phase 1 Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer steps up clinical trials for children’s vaccine Brian Niemietz June 8, 2021, 2:45 PM Drug company Pfizer is pushing a COVID-19 vaccine for children 5 to 11 years old into Phase 2/3 clinical trials. ABC News reports that based on successful Phase 1 trials, the jab for kids in that age range will contain 10 micrograms of vaccine each, which is one-third the potency the dose given to those 12 and over. Children 5 and under will receive 3 microgram shots. Noah Chen, 13, gets a shot of the Pfizer COVID-19 vaccine at the First Baptist Church of Pasadena, Friday, May 14, 2021, in Pasadena, ...

Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for COVID-19 in Feb-March India Updated: Friday, January 8, 2021, 13:17 [IST] Hyderabad, Jan 08: Buoyed by theEmergency Use Authorisation approval from theDrug Controller General of India (DCGI)for its COVID-19 vaccine Covaxin,Bharat Biotech has said Phase-1 clinical trials of its new intranasal antidote for the killer virus will begin during February-March this year. Besides Covaxin, BharatBiotechhas been actively working on developing another vaccine, for which it tied up with Washington UniversitySchool of Medicine in St Loui...

Updated Jan 08, 2021 | 15:11 IST Bharat Biotech has said Phase-1 clinical trials of its new intranasal antidote for the killer virus will begin during February-March this year. Representational image  |  Photo Credit: PTI New Delhi: The Bharat Biotech International Limited sent an application to the Drugs Controller General of India (DCGI) for conducting the phase 1 trials of an intranasal vaccine against the Covid-19 vaccine, a government official said on Friday. The matter is yet to be taken up," the government official added. The company has said Phas...